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Background and Introduction 
•  Inclusion Criteria: 
•  Patients ages 9-72 months who visited Jefferson Family Medicine 
Associates Practice (JFMA) between 4/1/2015-6/15/2015, 
9/8/2015-11/16/2015, or 1/4/2016-3/13/2016 without prior lead screening 
 
•  Interventions:  
•  Initiation of on-site lead filter paper testing on 8/12/2015 
•  Email to Providers on 8/12/2015 
•  Medical Assistant Education 8/2015 
•  QI PowerPoint presentation 9/3/2015 
 
•  Measures:  
•  Number of lead tests ordered and resulted during pre-  and post-
intervention period 
•  Number of on-site lead testing completed post-intervention 
Results Subgroup Analysis 
Conclusions 
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Materials and Methods 
 
•  Elevated blood lead levels (BLL) can cause multiple deleterious effects in 
pediatric patients, leading to neurological disease and delays in development 1, 5 
•  The CDC and state governments have made recommendations for screening in 
pediatric patients to allow for prompt intervention 1, 4, 5  
 
•  Two blood lead tests for children at “higher risk”: one at age 9-12 
months and one at age 2 years; screening should be done at 36-72 
months if no prior test completed 
•  The Philadelphia Department of Health has recommended that 100% of 
children be screened due to housing conditions 2, 3, 4 
 
 
•  In Philadelphia, only 26.80% of children under  the age of             
7  have been appropriately screened; in Pennsylvania, the                                           
number is only 14.05% 3 
 
2014-2015 Quality Improvement Lead Study: 
•  Provider reminders within the EMR pediatric note template 
significantly increased provider ordering behavior (p<0.0001) 
•  However, this did not lead to a significant increase in resulted lead 
screening tests (p = 0.8485) 
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•  Availability of on-site lead testing increased the rate of appropriate lead screening 
•  Over time, the percentage of pediatric patients eligible to be screened decreased 
•  Short term increase of physician/MA ordering practices following education but 
was not sustained  
 
Future Directions 
 
●  Qualitative analysis of barriers to Lead Test ordering 
 
●  Determine need and feasibility for on-site hemoglobin assessment in addition to 
on-site lead testing 
 
●  Introduce a pediatric checklist  
 
•  Medical Assistants 
•  Dr.  Victor  Diaz  
•  Thomas  Jefferson University  Hospital, Department of Family and Community 
Medicine 
 
Study Aims: 
Examine the effect of on-site lead screening collection on resulted lead screening 
rates. 
 
Proportion of Tests Ordered that were Completed 
 
Percentage of Eligible Patients 
Pre-
intervention 
Post- 
intervention 
#1 
Post- 
intervention 
#2 
Provider Ordering Behavior 
Eligible Patients 
Lead Test Ordered 32 32 8 
No Lead Test Ordered 58 46 47 
p-value 0.5251 0.0071* 
Appropriate Lead Screening 
Lead Test Ordered 
Test Resulted 14 29 8 
Test Not Resulted 18 3 0 
p-value 0.0001 * 0.0047 * 
Post Intervention Group # 1 Post Intervention Group # 2 
Fischer’s Test Analysis  
